Spreadsheet: 829846d1684487526-using-a-sumifs-formula-to-add-up-invoices-purchase-orders-in-a-date-range-test-dashboard
Sheet: Transactions

Posting Date | Document Type | Document No. | G/L Account No. | Description | Business stream Code | Department Code | £ Amount | $ Inv Amount | External Document No. | Clinical trial Code | Vendor | Category | Purchase Order No | Period Date | $ PO Amount | Version | $ [NAME] | $ Forecast Amount | $ [NAME] | Invoice Attachment
2021-08-01 00:00:00 | Invoice | 108629 | 50102 | Notebooks and Study Manuals | RD | FADRACICLIB | 116.92 | 162.5 | 311345 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108629 | 50102 | Shipping | RD | FADRACICLIB | 78.01 | 108.42 | 311345 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108629 | 50102 | IRB Fees | RD | FADRACICLIB | 3399.75 | 4725 | 311345 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108629 | 50102 | Translations | RD | FADRACICLIB | 4473.04 | 6216.68 | 311345 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Study Setup and Plan Development | RD | FADRACICLIB | 56142.13 | 78026.9 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Study Setup per Country | RD | FADRACICLIB | 24866.71 | 34560 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Study Setup Per Site | RD | FADRACICLIB | 2253.55 | 3132 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | System Setup | RD | FADRACICLIB | 44034.79 | 61200 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Core Document Package - Protocol Review for Scientific Specialist | RD | FADRACICLIB | 676.72 | 940.5 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Core Document Package - Informed Consent Development + Variations | RD | FADRACICLIB | 18146.48 | 25220.16 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Clinical Trial Submission to Central and Local IRBs | RD | FADRACICLIB | 4546 | 6318.9 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 119.94 | 166.7 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Monitoring Management Pre-study | RD | FADRACICLIB | 14003.5 | 19462.2 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Project Management (Pre-Study) | RD | FADRACICLIB | 32214.96 | 44772.68 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Planning and Risk Management | RD | FADRACICLIB | 15751.44 | 21891.5 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Functional Oversight | RD | FADRACICLIB | 22303.08 | 30997.04 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | EDC Support | RD | FADRACICLIB | 448.14 | 622.84 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Kick-off Meeting | RD | FADRACICLIB | 14036.45 | 19508 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Customer Teleconferences | RD | FADRACICLIB | 12591.88 | 17500.32 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 13090.31 | 18193.03 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Database/CRF Development** | RD | FADRACICLIB | 159787.63 | 222074.45 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | Clinical Discount Applied | RD | FADRACICLIB | -43501.42 | -60458.72 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-08-01 00:00:00 | Invoice | 108628 | 50102 | 2nd Clinical Discount Applied | RD | FADRACICLIB | -4350.15 | -6045.87 | 311346 | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00
2021-06-30 00:00:00 | [NAME] |  | 50102 | Study Setup and Plan Development | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 78026.9 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Study Setup Per Country | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 34560 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Study Setup Per Site | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 3132 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | System Setup | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 61200 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Core Document Package - Protocol Review for Scientific Specialist | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 940.5 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Core Document Package - Informed Consent Development + Variations | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 25220.16 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Clinical Trial Submission to Central and Local IRBs | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 6318.9 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | SSU Ongoing Activities | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 166.7 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Monitoring Management Pre-study | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 19462.2 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Project Management (Pre-Study) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 44772.68 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Planning and Risk Management | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 21891.5 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Functional Oversight | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 30997.04 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | EDC Support | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 622.84 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Kick-off Meeting | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 19508 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Customer Teleconferences | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 17500.32 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Internal Team Meetings | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 18193.04 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Database/CRF Development** | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 222074.45 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Clinical Discount Applied | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | -60458.72 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | 2nd Clinical Discount Applied | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | -6045.87 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Notebooks and Study Manuals | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 162.5 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Shipping | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 108.42 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | IRB Fees | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 4725 | ISA
2021-06-30 00:00:00 | [NAME] |  | 50102 | Translations | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106198 | 2021-06-01 00:00:00 | 6216.68 | ISA
2021-08-31 00:00:00 | [NAME] |  | 50102 | Study Setup and Plan Development | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 81604.74
2021-08-31 00:00:00 | [NAME] |  | 50102 | Study Setup Per Country | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 32680
2021-08-31 00:00:00 | [NAME] |  | 50102 | Study Setup Per Site | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 4698
2021-08-31 00:00:00 | [NAME] |  | 50102 | System Setup | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 86104
2021-08-31 00:00:00 | [NAME] |  | 50102 | DSMB Setup | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 21876
2021-08-31 00:00:00 | [NAME] |  | 50102 | Core Document Package - Protocol Review for Scientific Specialist | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 940.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Core Document Package - Informed Consent Development + Variations | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 25220.16
2021-08-31 00:00:00 | [NAME] |  | 50102 | Core Document Package - ICF Review and Completion of Study Labels | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 2268
2021-08-31 00:00:00 | [NAME] |  | 50102 | Core Document Package (for Amendments) Creation and Submission with ICF change | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 8007.2
2021-08-31 00:00:00 | [NAME] |  | 50102 | Core Document Package (for Notifications) Creation and Submission | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0
2021-08-31 00:00:00 | [NAME] |  | 50102 | Site Activation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 2457
2021-08-31 00:00:00 | [NAME] |  | 50102 | Clinical Trial Submission to Central and Local IRBs | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 18956.7
2021-08-31 00:00:00 | [NAME] |  | 50102 | Protocol Amendment Submission to Central and Local IRBs | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 5712
2021-08-31 00:00:00 | [NAME] |  | 50102 | SSU Ongoing Activities | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 1987.1567
2021-08-31 00:00:00 | [NAME] |  | 50102 | Site Initiation Visit | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 5059
2021-08-31 00:00:00 | [NAME] |  | 50102 | Site Initiation Visit by Phone | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 3322.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Interim Site Monitoring Visit | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 132965
2021-08-31 00:00:00 | [NAME] |  | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 94115
2021-08-31 00:00:00 | [NAME] |  | 50102 | Interim Site Monitoring Additional Days on Site | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 106650
2021-08-31 00:00:00 | [NAME] |  | 50102 | Site Monitoring Calls | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 15610
2021-08-31 00:00:00 | [NAME] |  | 50102 | Interim Site Monitoring Visit (follow-up) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0
2021-08-31 00:00:00 | [NAME] |  | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 87663.35
2021-08-31 00:00:00 | [NAME] |  | 50102 | Site Closeout Visit | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 15177
2021-08-31 00:00:00 | [NAME] |  | 50102 | Risk Assessment Maintenance | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 6000
2021-08-31 00:00:00 | [NAME] |  | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 28057.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 19253.60000000001
2021-08-31 00:00:00 | [NAME] |  | 50102 | Review of Clinical Listings, Custom and Vendor Reports | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 25335
2021-08-31 00:00:00 | [NAME] |  | 50102 | Monitoring Management Pre-study | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 39981.39
2021-08-31 00:00:00 | [NAME] |  | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 514123.53
2021-08-31 00:00:00 | [NAME] |  | 50102 | Monitoring Management Follow-up | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0
2021-08-31 00:00:00 | [NAME] |  | 50102 | Monitoring Management Closeout | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 54463.43
2021-08-31 00:00:00 | [NAME] |  | 50102 | Site Management | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 33810.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Investigator (PI) Calls | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 2085
2021-08-31 00:00:00 | [NAME] |  | 50102 | Lab Reconciliation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 69888
2021-08-31 00:00:00 | [NAME] |  | 50102 | Protocol Amendment (eDC updates requiring review by Central Monitoring) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 3584
2021-08-31 00:00:00 | [NAME] |  | 50102 | Medical Management Oversight | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 77085.70000000001
2021-08-31 00:00:00 | [NAME] |  | 50102 | Patient Eligibility Review | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 16228.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Medical Review of Patient Profiles | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 12820
2021-08-31 00:00:00 | [NAME] |  | 50102 | Investigator (PI) Calls | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 4807.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Project Management (Pre-Study) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 79795.48
2021-08-31 00:00:00 | [NAME] |  | 50102 | Planning and Risk Management | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 32060.4
2021-08-31 00:00:00 | [NAME] |  | 50102 | Project Management (Ongoing) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 645867.53
2021-08-31 00:00:00 | [NAME] |  | 50102 | Project Management (Ongoing) (January 1, 2023- April 30, 2023) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 124279
2021-08-31 00:00:00 | [NAME] |  | 50102 | Project Management (Closeout) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 74397.915
2021-08-31 00:00:00 | [NAME] |  | 50102 | Project Management (Follow-up ) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0
2021-08-31 00:00:00 | [NAME] |  | 50102 | Functional Oversight | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 218193.43
2021-08-31 00:00:00 | [NAME] |  | 50102 | EDC Support | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 5066.04
2021-08-31 00:00:00 | [NAME] |  | 50102 | Lab Reconciliation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0
2021-08-31 00:00:00 | [NAME] |  | 50102 | Kick-off Meeting | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 17818
2021-08-31 00:00:00 | [NAME] |  | 50102 | Mid-Study Project Team Meetings | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 4487
2021-08-31 00:00:00 | [NAME] |  | 50102 | Sponsor Teleconferences | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 137685.35
2021-08-31 00:00:00 | [NAME] |  | 50102 | Internal Team Meetings | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 147835.6
2021-08-31 00:00:00 | [NAME] |  | 50102 | Database/CRF Development** | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 280348.22
2021-08-31 00:00:00 | [NAME] |  | 50102 | External Data Sources | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 7544
2021-08-31 00:00:00 | [NAME] |  | 50102 | Customer Requested Custom Listings/Reports | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 8212.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Patient Profile Programming | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 53944
2021-08-31 00:00:00 | [NAME] |  | 50102 | Data Processing / Cleaning | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 24513.70999999999
2021-08-31 00:00:00 | [NAME] |  | 50102 | Data Coding | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 3663
2021-08-31 00:00:00 | [NAME] |  | 50102 | External Data Reconciliation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 25898
2021-08-31 00:00:00 | [NAME] |  | 50102 | External Data Uploads | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 23500
2021-08-31 00:00:00 | [NAME] |  | 50102 | Local Lab Normal Range Management including LOINC collection, management & validation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 9390
2021-08-31 00:00:00 | [NAME] |  | 50102 | Data Migrations | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 48689.44
2021-08-31 00:00:00 | [NAME] |  | 50102 | Database Locks | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 49683.99
2021-08-31 00:00:00 | [NAME] |  | 50102 | IXRS Development | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0
2021-08-31 00:00:00 | [NAME] |  | 50102 | Statistical Analysis Plan and Shells | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 39166.1
2021-08-31 00:00:00 | [NAME] |  | 50102 | SDTM Generation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 84256.92
2021-08-31 00:00:00 | [NAME] |  | 50102 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 80029.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Interim Analysis (end of Phase 1) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 62791
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Setup PH II | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 2800 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] Close | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 1000 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF PM Fee | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 9600.01 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 315 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | Materials | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 2055 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | Materials | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 2055 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | Materials | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 2055 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Documentation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 310 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Documentation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 310 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Documentation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 310 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 3150 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 3150 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 3150 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Production | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 1711.62 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Production | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 1711.62 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Production | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 1716.76 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Rec Drug | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 810 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] CRT PLT | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 11700 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Ship Ctrl Tmp | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 14000 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Shipper MD Dom | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 9600 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Tempmonitor | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 5600 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] PLT | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 1350 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 880 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | RF Dest PLT | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 460 | Original WO
2021-08-05 00:00:00 | [NAME] |  | 51620 | Courier Fees | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2021-08-01 00:00:00 | 21440 | Original WO
2021-08-31 00:00:00 | [NAME] |  | 50102 | Phase 2 Simon 2-Stage Futility Analysis | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 19087.6
2021-08-31 00:00:00 | [NAME] |  | 50102 | Official SDTM transfers | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 18960
2021-08-31 00:00:00 | [NAME] |  | 50102 | Final Unique Tables/Figures | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 112776.75
2021-08-31 00:00:00 | [NAME] |  | 50102 | Final Replicate Table/Figures | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 33433.75
2021-08-31 00:00:00 | [NAME] |  | 50102 | Final Unique Listings | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 38027.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Annual Safety Update | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 64208
2021-08-31 00:00:00 | [NAME] |  | 50102 | Pinnacle 21 Enterprise Annual License Fee | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 6045
2021-08-31 00:00:00 | [NAME] |  | 50102 | DSMB Management | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 79905
2021-08-31 00:00:00 | [NAME] |  | 50102 | Initial Generation of TLFs | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 97507
2021-08-31 00:00:00 | [NAME] |  | 50102 | Generation of TLFs for subsequent meetings | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 102956.25
2021-08-31 00:00:00 | [NAME] |  | 50102 | Submission of End of Trial Notifications | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 911.25
2021-08-31 00:00:00 | [NAME] |  | 50102 | Study Archival | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 13920
2021-08-31 00:00:00 | [NAME] |  | 50102 | One time discount | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0
2021-08-31 00:00:00 | [NAME] |  | 50102 | 1% One Time Discount | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | -83366.37
2021-08-31 00:00:00 | [NAME] |  | 50102 | 10% [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | -453602.6
2021-08-31 00:00:00 | [NAME] |  | 50102 | Roundings | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 0.01
2021-08-31 00:00:00 | [NAME] |  | 50102 | Notebooks and Study Manuals | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 487.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | Monitoring Travel | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 32770.64999999999
2021-08-31 00:00:00 | [NAME] |  | 50102 | DSMB | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 45870
2021-08-31 00:00:00 | [NAME] |  | 50102 | Shipping | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 1308.5
2021-08-31 00:00:00 | [NAME] |  | 50102 | IRB Fees | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 8520
2021-08-31 00:00:00 | [NAME] |  | 50102 | Translations | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 6216.68
2021-08-31 00:00:00 | [NAME] |  | 50102 | Licensing/System Fees | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-01 00:00:00 | 70267
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Study Setup and Plan Development | RD | FADRACICLIB | 58366.39 | 80356.74 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Study Setup Per Country | RD | FADRACICLIB | 25113.96 | 34576 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Study Setup Per Site | RD | FADRACICLIB | 2274.9 | 3132 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | System Setup | RD | FADRACICLIB | 62540.86 | 86104 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Core Document Package - Protocol Review for Scientific Specialist | RD | FADRACICLIB | 683.12 | 940.5 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Core Document Package - Informed Consent Development + Variations | RD | FADRACICLIB | 9159.22 | 12610.08 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Core Document Package - ICF Review and Completion of Study Labels | RD | FADRACICLIB | 1647.34 | 2268 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 118.84 | 163.62 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Risk Assessment Maintenance | RD | FADRACICLIB | 726.34 | 1000 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Monitoring Management Pre-study | RD | FADRACICLIB | 18229.17 | 25097.26 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Site Management | RD | FADRACICLIB | 1964.63 | 2704.84 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Project Management (Pre-Study) | RD | FADRACICLIB | 35557.5 | 48954.28 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Planning and Risk Management | RD | FADRACICLIB | 14286.37 | 19668.96 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Functional Oversight | RD | FADRACICLIB | 21792.74 | 30003.46 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | EDC Support | RD | FADRACICLIB | 441.14 | 607.34 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Kick-off Meeting | RD | FADRACICLIB | 14383 | 19802 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 13417.2 | 18472.32 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 13466.51 | 18540.2 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | One time discount | RD | FADRACICLIB | -60575.07 | -83397.57 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-03 00:00:00 | Invoice | 108663 | 50102 | 10% [NAME] | RD | FADRACICLIB | -23586.54 | -32473.1 | 316722 | CYC065-102 | Test Company 1 |  | 106205 | 2021-08-30 00:00:00
2021-09-30 00:00:00 | Invoice | 108770 | 51620 | RF Documentation | RD | FADRACICLIB | 230.34 | 310 | 868182 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-09-01 00:00:00
2021-09-30 00:00:00 | Invoice | 108770 | 51620 | [NAME] | RD | FADRACICLIB | 2340.55 | 3150 | 868182 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-09-01 00:00:00
2021-09-30 00:00:00 | Invoice | 108770 | 51620 | RF Production | RD | FADRACICLIB | 183.32 | 246.72 | 868182 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-09-01 00:00:00
2021-09-30 00:00:00 | Invoice | 108769 | 51620 | [NAME] | RD | FADRACICLIB | 241.49 | 325 | 868228 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-09-01 00:00:00
2021-09-30 00:00:00 | Invoice | 108769 | 51620 | RF Materials | RD | FADRACICLIB | 1110.38 | 1494.4 | 868228 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-09-01 00:00:00
2021-09-30 00:00:00 | Invoice | 108768 | 51620 | [NAME] | RD | FADRACICLIB | 2080.49 | 2800 | 868169 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-09-01 00:00:00
2021-09-30 00:00:00 | Invoice | 108768 | 51620 | RF PM Fee | RD | FADRACICLIB | 237.77 | 320 | 868169 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-09-01 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Core Document Package - Informed Consent Development + Variations | RD | FADRACICLIB | 9369.68 | 12610.08 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Clinical Trial Submission to Central and Local IRBs | RD | FADRACICLIB | 4695.14 | 6318.9 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 60.78 | 81.81 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Monitoring Management Pre-study | RD | FADRACICLIB | 9324.03 | 12548.63 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Site Management | RD | FADRACICLIB | 1004.88 | 1352.42 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Project Management (Pre-Study) | RD | FADRACICLIB | 18187.28 | 24477.14 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Planning and Risk Management | RD | FADRACICLIB | 7307.32 | 9834.48 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Functional Oversight | RD | FADRACICLIB | 11146.75 | 15001.73 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | EDC Support | RD | FADRACICLIB | 225.64 | 303.67 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 6862.75 | 9236.16 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 9839.96 | 13243 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | 10% [NAME] | RD | FADRACICLIB | -10297.11 | -13858.25 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-10-14 00:00:00 | Invoice | 108785 | 50102 | IXRS Development | RD | FADRACICLIB | 23955.32 | 32240 | 320003 | CYC065-102 | Test Company 1 |  | 106205 | 2021-09-30 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | DSMB Setup | RD | FADRACICLIB | 15995.36 | 21876 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Site Activation | RD | FADRACICLIB | 598.83 | 819 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 59.82 | 81.81 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Site Initiation Visit by Phone | RD | FADRACICLIB | 809.79 | 1107.5 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 2179.23 | 2980.42 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Monitoring Management Pre-study | RD | FADRACICLIB | 2385.59 | 3262.64 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 10820.99 | 14799.3 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Site Management | RD | FADRACICLIB | 988.87 | 1352.42 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 5690.11 | 7782.07 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 474.64 | 649.14 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Project Management (Pre-Study) | RD | FADRACICLIB | 4653.29 | 6364.06 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Planning and Risk Management | RD | FADRACICLIB | 1869.61 | 2556.96 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 17680.16 | 24180.22 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Functional Oversight | RD | FADRACICLIB | 10969.01 | 15001.73 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | EDC Support | RD | FADRACICLIB | 222.04 | 303.67 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 6753.32 | 9236.16 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 7746.44 | 10594.4 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Database/CRF Development** | RD | FADRACICLIB | 191937.1 | 262502.2 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Local Lab Normal Range Management including LOINC collection, management & validation | RD | FADRACICLIB | 1144.3 | 1565 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | 10% [NAME] | RD | FADRACICLIB | -28572.99 | -39077.77 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108862 | 50102 | Roundings | RD | FADRACICLIB | 0.01 | 0.01 | 322950 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-10 00:00:00 | Invoice | 108861 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 8280.1 | 11324.25 | 322978 | CYC065-102 | Test Company 1 |  | 106205 | 2021-10-01 00:00:00
2021-11-08 00:00:00 | Invoice | 108855 | 51620 | RF PM Fee | RD | FADRACICLIB | 233.98 | 320 | 870214 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-10-01 00:00:00
2021-11-08 00:00:00 | Invoice | 108855 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 95.05 | 130 | 870214 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-10-01 00:00:00
2021-11-08 00:00:00 | Invoice | 108855 | 51620 | RF Ship CRT | RD | FADRACICLIB | 127.96 | 175 | 870214 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-10-01 00:00:00
2021-11-08 00:00:00 | Invoice | 108855 | 51620 | RF Shipper SM Dom | RD | FADRACICLIB | 54.84 | 75 | 870214 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-10-01 00:00:00
2021-11-08 00:00:00 | Invoice | 108855 | 51620 | RF Tempmonitor | RD | FADRACICLIB | 51.18 | 70 | 870214 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-10-01 00:00:00
2021-11-08 00:00:00 | Invoice | 108855 | 51620 | RF Fedex Frt | RD | FADRACICLIB | 94.78 | 129.63 | 870214 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-10-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Clinical Trial Submission to Central and Local IRBs | RD | FADRACICLIB | 4746.11 | 6318.9 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 61.45 | 81.81 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 3997.47 | 5322.17 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 19849.49 | 26427.32 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Site Management | RD | FADRACICLIB | 507.9 | 676.21 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 10437.67 | 13896.56 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Medical Review of Patient Profiles | RD | FADRACICLIB | 481.46 | 641 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 32431.61 | 43178.97 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Functional Oversight | RD | FADRACICLIB | 11267.77 | 15001.73 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | EDC Support | RD | FADRACICLIB | 228.08 | 303.67 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 5202.95 | 6927.12 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 5968.07 | 7945.8 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | Pinnacle 21 Enterprise Annual License Fee | RD | FADRACICLIB | 2270.19 | 3022.5 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | DSMB Management | RD | FADRACICLIB | 9812.92 | 13064.78 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108958 | 50102 | 10% [NAME] | RD | FADRACICLIB | -10830.61 | -14419.71 | 325763 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-12-09 00:00:00 | Invoice | 108921 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2274.31 | 3027.98 | 325718 | CYC065-102 | Test Company 1 |  | 106205 | 2021-11-01 00:00:00
2021-11-30 00:00:00 | Invoice | 108901 | 51620 | RF PM Fee | RD | FADRACICLIB | 240.35 | 320 | 872722 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-11-01 00:00:00
2021-11-30 00:00:00 | Invoice | 108901 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 97.64 | 130 | 872722 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-11-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 60.55 | 81.81 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Site Initiation Visit by Phone | RD | FADRACICLIB | 819.74 | 1107.5 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 1990.31 | 2689 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 3939.31 | 5322.17 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Risk Assessment Maintenance | RD | FADRACICLIB | 740.17 | 1000 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 461.49 | 623.5 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB | 712.55 | 962.68 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 19560.68 | 26427.32 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Site Management | RD | FADRACICLIB | 1001.02 | 1352.42 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 10285.8 | 13896.56 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 31959.73 | 43178.97 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Functional Oversight | RD | FADRACICLIB | 11103.81 | 15001.73 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | EDC Support | RD | FADRACICLIB | 224.77 | 303.67 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3418.16 | 4618.08 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 3920.82 | 5297.2 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Data Processing / Cleaning | RD | FADRACICLIB | 693.87 | 937.45 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | Local Lab Normal Range Management including LOINC collection, management & validation | RD | FADRACICLIB | 3475.1 | 4695 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-11 00:00:00 | Invoice | 109030 | 50102 | 10% [NAME] | RD | FADRACICLIB | -9528.54 | -12873.47 | 328635 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-10 00:00:00 | Invoice | 109009 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 1773.96 | 2396.69 | 328102 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-10 00:00:00 | Invoice | 109009 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2241.21 | 3027.98 | 328102 | CYC065-102 | Test Company 1 |  | 106205 | 2021-12-01 00:00:00
2022-01-05 00:00:00 | Invoice | 108990 | 51620 | RF PM Fee | RD | FADRACICLIB | 236.85 | 320 | 874813 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-12-01 00:00:00
2022-01-05 00:00:00 | Invoice | 108990 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 96.23 | 130 | 874813 RI | CYC065-102 | Test Company 2 |  | 106202 | 2021-12-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | IXRS Development | RD | FADRACICLIB | -24081.18 | -32240 | 335478 | CYC065-101 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 61.11 | 81.81 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 2008.5 | 2689 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 3975.32 | 5322.17 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 465.71 | 623.5 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB | 719.06 | 962.68 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 19739.49 | 26427.32 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Site Management | RD | FADRACICLIB | 1010.16 | 1352.42 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 10379.83 | 13896.56 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 484.86 | 649.14 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Medical Review of Patient Profiles | RD | FADRACICLIB | 478.79 | 641 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 32251.87 | 43178.97 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Functional Oversight | RD | FADRACICLIB | 11205.32 | 15001.73 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | EDC Support | RD | FADRACICLIB | 226.82 | 303.67 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3449.4 | 4618.08 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 3956.67 | 5297.2 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109220 | 50102 | 10% [NAME] | RD | FADRACICLIB | -6697.67 | -8966.87 | 335478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-02-21 00:00:00 | Invoice | 109131 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2254.84 | 3027.98 | 331373 | CYC065-102 | Test Company 1 |  | 106205 | 2022-01-01 00:00:00
2022-01-31 00:00:00 | Invoice | 109085 | 51620 | RF PM Fee | RD | FADRACICLIB | 238.29 | 320 | 877248 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-01-01 00:00:00
2022-01-31 00:00:00 | Invoice | 109085 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 96.81 | 130 | 877248 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-01-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Site Activation | RD | FADRACICLIB | 611.74 | 819 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 61.11 | 81.81 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 4017.01 | 5378 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 3975.32 | 5322.17 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 931.42 | 1247 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 19739.49 | 26427.32 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Site Management | RD | FADRACICLIB | 505.08 | 676.21 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 10379.83 | 13896.56 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 32251.87 | 43178.97 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Functional Oversight | RD | FADRACICLIB | 11205.31 | 15001.73 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | EDC Support | RD | FADRACICLIB | 226.82 | 303.67 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3449.41 | 4618.08 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 3956.66 | 5297.2 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-28 00:00:00 | Invoice | 109221 | 50102 | 10% [NAME] | RD | FADRACICLIB | -9219.88 | -12343.63 | 335479 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-03-15 00:00:00 | Invoice | 109189 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2261.7 | 3027.98 | 334112 | CYC065-102 | Test Company 1 |  | 106205 | 2022-02-01 00:00:00
2022-04-30 00:00:00 | Invoice | 109335 | 51620 | [NAME] | RD | FADRACICLIB | 258.15 | 324.45 | 880978 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-02-01 00:00:00
2022-04-30 00:00:00 | Invoice | 109335 | 51620 | RF Materials | RD | FADRACICLIB | 1684.1 | 2116.65 | 880978 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-02-01 00:00:00
2022-02-28 00:00:00 | Invoice | 109172 | 51620 | RF Documentation | RD | FADRACICLIB | 238.5 | 319.3 | 880980 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-02-01 00:00:00
2022-02-28 00:00:00 | Invoice | 109172 | 51620 | [NAME] | RD | FADRACICLIB | 2423.43 | 3244.5 | 880980 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-02-01 00:00:00
2022-02-28 00:00:00 | Invoice | 109172 | 51620 | RF Production | RD | FADRACICLIB | 142.28 | 190.5 | 880980 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-02-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 62.3 | 81.81 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 474.77 | 623.5 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 20123.6 | 26427.32 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Site Management | RD | FADRACICLIB | 1029.83 | 1352.42 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 10581.81 | 13896.56 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 32879.47 | 43178.97 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Functional Oversight | RD | FADRACICLIB | 11423.37 | 15001.73 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | EDC Support | RD | FADRACICLIB | 231.23 | 303.67 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3516.53 | 4618.08 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 4033.66 | 5297.2 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | 10% [NAME] | RD | FADRACICLIB | -8310.93 | -10914.32 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-19 00:00:00 | Invoice | 109286 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | -2047.59 | -2689 | 337478 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-04-14 00:00:00 | Invoice | 109287 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2305.71 | 3027.98 | 336817 | CYC065-102 | Test Company 1 |  | 106205 | 2022-03-01 00:00:00
2022-03-16 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-03-01 00:00:00 | 315 | CO 1
2022-03-16 00:00:00 | [NAME] |  | 51620 | RF Materials | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-03-01 00:00:00 | 2055 | CO 1
2022-03-16 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-03-01 00:00:00 | 3150 | CO 1
2022-03-16 00:00:00 | [NAME] |  | 51620 | RF Documentation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-03-01 00:00:00 | 310 | CO 1
2022-03-16 00:00:00 | [NAME] |  | 51620 | RF Production | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-03-01 00:00:00 | 184.8 | CO 1
2022-05-11 00:00:00 | Invoice | 109362 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2409.2 | 3027.98 | 339540 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 65.09 | 81.81 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 4278.99 | 5378 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 992.17 | 1247 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Site Management | RD | FADRACICLIB | 1076.05 | 1352.42 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11056.74 | 13896.56 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 34355.19 | 43178.97 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Functional Oversight | RD | FADRACICLIB | 11936.07 | 15001.73 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | EDC Support | RD | FADRACICLIB | 241.61 | 303.67 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3674.36 | 4618.08 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 4214.69 | 5297.2 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-05-11 00:00:00 | Invoice | 109361 | 50102 | 10% [NAME] | RD | FADRACICLIB | -7258.99 | -9123.4 | 339798 | CYC065-102 | Test Company 1 |  | 106205 | 2022-04-01 00:00:00
2022-04-30 00:00:00 | Invoice | 109322 | 51620 | RF PM Fee | RD | FADRACICLIB | 262.24 | 329.6 | 886193 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-04-01 00:00:00
2022-04-30 00:00:00 | Invoice | 109322 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 106.54 | 133.9 | 886193 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-04-01 00:00:00
2022-06-30 00:00:00 | Invoice | 109499 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2493.04 | 3027.98 | 344186 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 64.9 | 81.81 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 2133.19 | 2689 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 494.63 | 623.5 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 20964.88 | 26427.32 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Site Management | RD | FADRACICLIB | 1072.88 | 1352.42 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11024.18 | 13896.56 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 34254.02 | 43178.97 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Functional Oversight | RD | FADRACICLIB | 11900.92 | 15001.73 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | EDC Support | RD | FADRACICLIB | 240.9 | 303.67 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3663.54 | 4618.08 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 4202.29 | 5297.2 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-08 00:00:00 | Invoice | 109446 | 50102 | 10% [NAME] | RD | FADRACICLIB | -9089.16 | -11457.35 | 342087 | CYC065-102 | Test Company 1 |  | 106205 | 2022-05-01 00:00:00
2022-06-13 00:00:00 | Invoice | 109459 | 51620 | RF Materials | RD | FADRACICLIB | 1630.24 | 2055 | 888574 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-05-01 00:00:00
2022-05-31 00:00:00 | Invoice | 109438 | 51620 | RF Documentation | RD | FADRACICLIB | 253.3 | 319.3 | 888575 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-05-01 00:00:00
2022-05-31 00:00:00 | Invoice | 109438 | 51620 | [NAME] | RD | FADRACICLIB | 2573.87 | 3244.5 | 888575 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-05-01 00:00:00
2022-05-31 00:00:00 | Invoice | 109438 | 51620 | RF Production | RD | FADRACICLIB | 503.75 | 635 | 888575 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-05-01 00:00:00
2022-05-31 00:00:00 | Invoice | 109403 | 51620 | RF PM Fee | RD | FADRACICLIB | 261.47 | 329.6 | 889034 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-05-01 00:00:00
2022-05-31 00:00:00 | Invoice | 109403 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 212.45 | 267.8 | 889034 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-05-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 67.36 | 81.81 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 4381.92 | 5322.17 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 513.34 | 623.5 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Site Management | RD | FADRACICLIB | 1113.5 | 1352.42 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11441.5 | 13896.56 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 534.46 | 649.14 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Medical Review of Patient Profiles | RD | FADRACICLIB | 527.75 | 641 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 35550.68 | 43178.97 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Functional Oversight | RD | FADRACICLIB | 12351.43 | 15001.73 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | EDC Support | RD | FADRACICLIB | 250.02 | 303.67 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3802.22 | 4618.08 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 4361.36 | 5297.2 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-14 00:00:00 | Invoice | 109541 | 50102 | 10% [NAME] | RD | FADRACICLIB | -7562.37 | -9185.07 | 345597 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-07-11 00:00:00 | Invoice | 109521 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2493.04 | 3027.98 | 345047 | CYC065-102 | Test Company 1 |  | 106205 | 2022-06-01 00:00:00
2022-10-10 00:00:00 | Invoice | 109811 | 51620 | RF Materials | RD | FADRACICLIB | 1845.88 | 2055 | 892322 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-10-10 00:00:00 | Invoice | 109811 | 51620 | RF Materials | RD | FADRACICLIB | 1845.88 | 2055 | 892322 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-10-10 00:00:00 | Invoice | 109810 | 51620 | [NAME] | RD | FADRACICLIB | 2914.33 | 3244.5 | 892229 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-10-10 00:00:00 | Invoice | 109810 | 51620 | RF Documentation | RD | FADRACICLIB | 286.81 | 319.3 | 892229 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-10-10 00:00:00 | Invoice | 109810 | 51620 | RF Production | RD | FADRACICLIB | 359.34 | 400.05 | 892229 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-06-30 00:00:00 | Invoice | 109493 | 51620 | RF PM Fee | RD | FADRACICLIB | 271.37 | 329.6 | 891402 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-06-30 00:00:00 | Invoice | 109493 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 220.49 | 267.8 | 891402 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-06-30 00:00:00 | Invoice | 109484 | 51620 | [NAME] | RD | FADRACICLIB | 2671.3 | 3244.5 | 892230 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-06-30 00:00:00 | Invoice | 109484 | 51620 | RF Documentation | RD | FADRACICLIB | 262.9 | 319.3 | 892230 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-06-30 00:00:00 | Invoice | 109484 | 51620 | RF Production | RD | FADRACICLIB | 156.84 | 190.5 | 892230 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-06-30 00:00:00 | Invoice | 109484 | 51620 | RF Production | RD | FADRACICLIB | 47.05 | 57.15 | 892230 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-06-01 00:00:00
2022-08-30 00:00:00 | Invoice | 109671 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2486.96 | 3027.98 | 349686 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB | 790.67 | 962.68 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11413.59 | 13896.56 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 533.16 | 649.14 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 35463.96 | 43178.97 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | Functional Oversight | RD | FADRACICLIB | 12321.29 | 15001.73 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | EDC Support | RD | FADRACICLIB | 249.42 | 303.67 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3792.94 | 4618.08 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 4350.72 | 5297.2 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-08-11 00:00:00 | Invoice | 109633 | 50102 | 10% [NAME] | RD | FADRACICLIB | -6958.58 | -8472.39 | 348383 | CYC065-102 | Test Company 1 |  | 106205 | 2022-07-01 00:00:00
2022-07-31 00:00:00 | Invoice | 109585 | 51620 | RF PM Fee | RD | FADRACICLIB | 270.71 | 329.6 | 894416 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-07-01 00:00:00
2022-07-31 00:00:00 | Invoice | 109585 | 51620 | RF Ship CRT | RD | FADRACICLIB | 439.9 | 535.6 | 894416 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-07-01 00:00:00
2022-07-31 00:00:00 | Invoice | 109585 | 51620 | RF Shipper SM Dom | RD | FADRACICLIB | 444.13 | 540.75 | 894416 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-07-01 00:00:00
2022-07-31 00:00:00 | Invoice | 109585 | 51620 | RF Tempmonitor | RD | FADRACICLIB | 190.34 | 231.75 | 894416 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-07-01 00:00:00
2022-07-31 00:00:00 | Invoice | 109585 | 51620 | RF Fedex Frt | RD | FADRACICLIB | 177.66 | 216.3 | 894416 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-07-01 00:00:00
2022-07-31 00:00:00 | Invoice | 109585 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 332.72 | 405.1 | 894416 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-07-01 00:00:00
2022-09-09 00:00:00 | Invoice | 109726 | 50102 | Other Meetings & Seminars | RD | FADRACICLIB | 1884.02 | 2192.86 | 350932 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-09 00:00:00 | Invoice | 109726 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 5471.13 | 6367.98 | 350932 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 70.29 | 81.81 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB | 827.1 | 962.68 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Site Management | RD | FADRACICLIB | 1161.94 | 1352.42 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11939.4 | 13896.56 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 37097.72 | 43178.97 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Functional Oversight | RD | FADRACICLIB | 12888.92 | 15001.73 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | EDC Support | RD | FADRACICLIB | 260.9 | 303.67 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 3967.68 | 4618.08 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 4551.15 | 5297.2 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | Data Processing / Cleaning | RD | FADRACICLIB | 9.26 | 10.78 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-09-05 00:00:00 | Invoice | 109696 | 50102 | 10% [NAME] | RD | FADRACICLIB | -7348.19 | -8552.75 | 350300 | CYC065-102 | Test Company 1 |  | 106205 | 2022-08-01 00:00:00
2022-10-11 00:00:00 | Invoice | 109812 | 51620 | RF PM Fee | RD | FADRACICLIB | 296.06 | 329.6 | 897226 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-08-01 00:00:00
2022-10-11 00:00:00 | Invoice | 109812 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 481.1 | 535.6 | 897226 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-08-01 00:00:00
2022-10-11 00:00:00 | Invoice | 109812 | 51620 | RF Ship CRT | RD | FADRACICLIB | 161.9 | 180.25 | 897226 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-08-01 00:00:00
2022-10-11 00:00:00 | Invoice | 109812 | 51620 | RF Shipper SM Dom | RD | FADRACICLIB | 69.39 | 77.25 | 897226 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-08-01 00:00:00
2022-10-11 00:00:00 | Invoice | 109812 | 51620 | RF Tempmonitor | RD | FADRACICLIB | 64.76 | 72.1 | 897226 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-08-01 00:00:00
2022-10-11 00:00:00 | Invoice | 109812 | 51620 | RF Fedex Frt | RD | FADRACICLIB | 129.43 | 144.09 | 897226 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-08-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 73.48 | 81.81 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 2415.37 | 2689 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Interim Site Monitoring Additional Days on Site | RD | FADRACICLIB | 7663.76 | 8532 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 2240.21 | 2494 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB | 2594.14 | 2888.04 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 23738.02 | 26427.32 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Site Management | RD | FADRACICLIB | 1214.79 | 1352.42 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 12482.42 | 13896.56 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 2915.41 | 3245.7 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Medical Review of Patient Profiles | RD | FADRACICLIB | 2303.08 | 2564 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 38784.98 | 43178.97 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Functional Oversight | RD | FADRACICLIB | 13475.12 | 15001.73 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | EDC Support | RD | FADRACICLIB | 272.77 | 303.67 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 4148.13 | 4618.08 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 4758.15 | 5297.2 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Data Processing / Cleaning | RD | FADRACICLIB | 5458.81 | 6077.25 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | Data Coding | RD | FADRACICLIB | 1184.49 | 1318.68 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | External Data Uploads | RD | FADRACICLIB | 1025.79 | 1142 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-11-01 00:00:00 | Invoice | 109961 | 50102 | 10% [NAME] | RD | FADRACICLIB | -12798.13 | -14248.04 | 354028 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-10-28 00:00:00 | Invoice | 109843 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2625.8 | 3027.98 | 355912 | CYC065-102 | Test Company 1 |  | 106205 | 2022-09-01 00:00:00
2022-09-13 00:00:00 | [NAME] |  | 51620 | RF Materials | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 2058 | CO 2
2022-09-13 00:00:00 | [NAME] |  | 51620 | RF Materials | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 2058 | CO 2
2022-09-13 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 3341.84 | CO 2
2022-09-13 00:00:00 | [NAME] |  | 51620 | RF Documentation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 328.88 | CO 2
2022-09-13 00:00:00 | [NAME] |  | 51620 | RF Production | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 376.26 | CO 2
2022-09-13 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 3341.84 | CO 2
2022-09-13 00:00:00 | [NAME] |  | 51620 | RF Documentation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 328.88 | CO 2
2022-09-13 00:00:00 | [NAME] |  | 51620 | RF Production | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00 | 1723.16 | CO 2
2022-10-11 00:00:00 | Invoice | 109813 | 51620 | RF PM Fee | RD | FADRACICLIB | 296.06 | 329.6 | 899827 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00
2022-10-11 00:00:00 | Invoice | 109813 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 360.82 | 401.7 | 899827 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-09-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 2242.11 | 2689 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Interim Site Monitoring Additional Days on Site | RD | FADRACICLIB | 3557.01 | 4266 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 4437.66 | 5322.17 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 519.88 | 623.5 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 22035.27 | 26427.32 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Site Management | RD | FADRACICLIB | 1127.66 | 1352.42 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11587.04 | 13896.56 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 541.26 | 649.14 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 36002.91 | 43178.97 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Functional Oversight | RD | FADRACICLIB | 12508.54 | 15001.73 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | EDC Support | RD | FADRACICLIB | 253.2 | 303.67 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Data Processing / Cleaning | RD | FADRACICLIB | 691.8 | 829.69 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Data Coding | RD | FADRACICLIB | 3.39 | 4.07 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB | 802.69 | 962.68 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 1925.3 | 2309.04 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 2208.42 | 2648.6 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | Medical Review of Patient profiles | RD | FADRACICLIB | -3741.29 | -4487 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-23 00:00:00 | Invoice | 109963 | 50102 | 10% [NAME] | RD | FADRACICLIB | -9764.31 | -11710.52 | 358360 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-11-10 00:00:00 | Invoice | 109914 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 5522.18 | 6367.98 | 357339 | CYC065-102 | Test Company 1 |  | 106205 | 2022-10-01 00:00:00
2022-10-26 00:00:00 | [NAME] |  | 51620 | RF Materials | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00 | 3276 | CO 3
2022-10-26 00:00:00 | [NAME] |  | 51620 | [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00 | 3341.84 | CO 3
2022-10-26 00:00:00 | [NAME] |  | 51620 | RF Documentation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00 | 328.88 | CO 3
2022-10-26 00:00:00 | [NAME] |  | 51620 | RF Production | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00 | 2999.16 | CO 3
2022-10-31 00:00:00 | Invoice | 109863 | 51620 | RF PM Fee | RD | FADRACICLIB | 285.82 | 329.6 | 902589 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109863 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 348.35 | 401.7 | 902589 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 51620 | RF Materials | RD | FADRACICLIB | 1784.65 | 2058 | 903379 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 51620 | [NAME] | RD | FADRACICLIB | 2897.98 | 3341.84 | 903379 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 51620 | RF Documentation | RD | FADRACICLIB | 285.19 | 328.88 | 903379 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 51620 | RF Production | RD | FADRACICLIB | 1493.46 | 1722.2 | 903379 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 50125 | RF Materials | RD | FADRACICLIB | 4027.92 | 4644.86 | 903379 RI | CYC065-101 | Test Company 2 |  | 106152 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 50125 | RF Materials | RD | FADRACICLIB | 3730.44 | 4301.81 | 903379 RI | CYC065-101 | Test Company 2 |  | 106152 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 50125 | RF Materials | RD | FADRACICLIB | 14207.3 | 16383.36 | 903379 RI | CYC065-101 | Test Company 2 |  | 106152 | 2022-10-01 00:00:00
2022-10-31 00:00:00 | Invoice | 109860 | 50125 | RF Materials | RD | FADRACICLIB | 2185.29 | 2520 | 903379 RI | CYC065-101 | Test Company 2 |  | 106152 | 2022-10-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 68.21 | 81.81 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 15694.74 | 18823 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Interim Site Monitoring Additional Days on Site | RD | FADRACICLIB | 10671.06 | 12798 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 4437.66 | 5322.17 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 2079.51 | 2494 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Central Monitoring Clinical Review | RD | FADRACICLIB | 802.69 | 962.68 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 22035.27 | 26427.32 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Site Management | RD | FADRACICLIB | 1127.66 | 1352.42 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11587.04 | 13896.56 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 36002.91 | 43178.97 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Functional Oversight | RD | FADRACICLIB | 12508.54 | 15001.73 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | EDC Support | RD | FADRACICLIB | 253.2 | 303.67 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 1925.29 | 2309.04 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 2208.42 | 2648.6 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | External Data Reconciliation | RD | FADRACICLIB | 11876.66 | 14243.9 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | External Data Uploads | RD | FADRACICLIB | 9522.07 | 11420 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Local Lab Normal Range Management including LOINC collection, management & validation | RD | FADRACICLIB | 5219.63 | 6260 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | Statistical Analysis Plan and Shells | RD | FADRACICLIB | 32656.95 | 39166.1 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 110003 | 50102 | 10% [NAME] | RD | FADRACICLIB | -18243.42 | -21879.68 | 359577 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-06 00:00:00 | Invoice | 109991 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2524.75 | 3027.98 | 359832 | CYC065-102 | Test Company 1 |  | 106205 | 2022-11-01 00:00:00
2022-12-31 00:00:00 | Invoice | 110110 | 51620 | RF PM Fee | RD | FADRACICLIB | 272.63 | 329.6 | 905248 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-11-01 00:00:00
2022-12-31 00:00:00 | Invoice | 110110 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 443.02 | 535.6 | 905248 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-11-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Interim Site Monitoring Additional Days on Site | RD | FADRACICLIB | 8821.56 | 10665 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 4402.23 | 5322.17 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 1547.19 | 1870.5 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 21859.37 | 26427.32 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Site Management | RD | FADRACICLIB | 1118.65 | 1352.42 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 11494.55 | 13896.56 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 35715.5 | 43178.97 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Functional Oversight | RD | FADRACICLIB | 12408.68 | 15001.73 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | EDC Support | RD | FADRACICLIB | 251.19 | 303.67 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | External Data Sources | RD | FADRACICLIB | 6021.65 | 7280 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Data Processing / Cleaning | RD | FADRACICLIB | 240.64 | 290.93 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | Data Coding | RD | FADRACICLIB | 478.05 | 577.94 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110129 | 50102 | 10% [NAME] | RD | FADRACICLIB | -10537.4 | -12739.39 | 363115 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2023-01-13 00:00:00 | Invoice | 110117 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2504.59 | 3027.98 | 363560 | CYC065-102 | Test Company 1 |  | 106205 | 2022-12-01 00:00:00
2022-12-31 00:00:00 | Invoice | 110087 | 51620 | RF PM Fee | RD | FADRACICLIB | 272.63 | 329.6 | 908095 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-12-01 00:00:00
2022-12-31 00:00:00 | Invoice | 110087 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 443.02 | 535.6 | 908095 RI | CYC065-102 | Test Company 2 |  | 106202 | 2022-12-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 66.36 | 81.81 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Interim Site Monitoring Additional Days on Site | RD | FADRACICLIB | 10380.65 | 12798 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 3786.22 | 4667.91 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 505.73 | 623.5 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 22205.19 | 27376.12 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Site Management | RD | FADRACICLIB | 1096.97 | 1352.42 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 3329.37 | 4104.67 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 35023.13 | 43178.97 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Functional Oversight | RD | FADRACICLIB | 7286.13 | 8982.85 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 2030.52 | 2503.37 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 2180.21 | 2687.92 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Data Coding | RD | FADRACICLIB | 359.84 | 443.63 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | External Data Reconciliation | RD | FADRACICLIB | 1050.31 | 1294.9 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | External Data Uploads | RD | FADRACICLIB | 953.06 | 1175 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | 10% [NAME] | RD | FADRACICLIB | -16469.76 | -20305.08 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 4362.18 | 5378 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Investigator (PI) Calls - Clinical | RD | FADRACICLIB | 338.23 | 417 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Lab Reconciliation | RD | FADRACICLIB | 23619.69 | 29120 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Protocol Amendment (eDC updates requiring review by Central Monitoring) | RD | FADRACICLIB | 2907.03 | 3584 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Investigator (PI) Calls - Medical | RD | FADRACICLIB | 779.89 | 961.5 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110278 | 50102 | Data Migrations | RD | FADRACICLIB | 39492.76 | 48689.44 | 366741 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-02-14 00:00:00 | Invoice | 110213 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2456.04 | 3027.98 | 366432 | CYC065-102 | Test Company 1 |  | 106205 | 2023-01-01 00:00:00
2023-01-31 00:00:00 | Invoice | 110162 | 51620 | RF PM Fee | RD | FADRACICLIB | 267.34 | 329.6 | 910559 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-01-01 00:00:00
2023-01-31 00:00:00 | Invoice | 110162 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 434.44 | 535.6 | 910559 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-01-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 66.15 | 81.81 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Essential Document / TMF Maintenance | RD | FADRACICLIB | 3774.47 | 4667.91 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 1008.32 | 1247 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 22136.3 | 27376.12 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Site Management | RD | FADRACICLIB | 1093.57 | 1352.42 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 3319.03 | 4104.67 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 2099.58 | 2596.56 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Project Management (Ongoing) | RD | FADRACICLIB | 34914.47 | 43178.97 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Functional Oversight | RD | FADRACICLIB | 7263.52 | 8982.85 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | EDC Support | RD | FADRACICLIB | 177.8 | 219.88 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 2024.22 | 2503.37 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 2173.45 | 2687.92 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Data Processing / Cleaning | RD | FADRACICLIB | 740.59 | 915.9 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Data Coding | RD | FADRACICLIB | 197.46 | 244.2 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | External Data Reconciliation | RD | FADRACICLIB | 1047.06 | 1294.9 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | 10% [NAME] | RD | FADRACICLIB | -9207.85 | -11387.41 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Investigator (PI) Calls - Clinical | RD | FADRACICLIB | 224.79 | 278 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Lab Reconciliation | RD | FADRACICLIB | 2354.64 | 2912 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 4348.65 | 5378 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | Investigator (PI) Calls - Medical | RD | FADRACICLIB | 518.31 | 641 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-04-01 00:00:00 | Invoice | 110401 | 50102 | External Data Uploads | RD | FADRACICLIB | 950.1 | 1175 | 369536 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-03-29 00:00:00 | Invoice | 110338 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2509.05 | 3027.98 | 370143 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-03-29 00:00:00 | Invoice | 110338 | 50102 | Other Meetings & Seminars | RD | FADRACICLIB | 3977.39 | 4800 | 370143 | CYC065-102 | Test Company 1 |  | 106205 | 2023-02-01 00:00:00
2023-03-17 00:00:00 | Invoice | 110312 | 51620 | RF PM Fee | RD | FADRACICLIB | 273.11 | 329.6 | 913263 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-02-01 00:00:00
2023-03-17 00:00:00 | Invoice | 110312 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 443.81 | 535.6 | 913263 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-02-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | SSU Ongoing Activities | RD | FADRACICLIB | 65.11 | 81.81 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB | 992.46 | 1247 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Monitoring Management Ongoing | RD | FADRACICLIB | 21788.11 | 27376.12 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Site Management | RD | FADRACICLIB | 1076.36 | 1352.42 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Medical Management Oversight | RD | FADRACICLIB | 3266.82 | 4104.67 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Patient Eligibility Review | RD | FADRACICLIB | 1033.28 | 1298.28 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Functional Oversight | RD | FADRACICLIB | 7149.27 | 8982.85 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | EDC Support | RD | FADRACICLIB | 175 | 219.88 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Sponsor Teleconferences | RD | FADRACICLIB | 1992.38 | 2503.37 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Internal Team Meetings | RD | FADRACICLIB | 2139.26 | 2687.92 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Customer Requested Custom Listings/Reports | RD | FADRACICLIB | 1307.23 | 1642.5 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Data Processing / Cleaning | RD | FADRACICLIB | 694.65 | 872.8 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Data Coding | RD | FADRACICLIB | 398.42 | 500.61 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | 10% [NAME] | RD | FADRACICLIB | -7657.22 | -9621.08 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Investigator (PI) Calls - Clinical | RD | FADRACICLIB | 221.25 | 278 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Lab Reconciliation | RD | FADRACICLIB | 2317.61 | 2912 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB | 2140.12 | 2689 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Site Monitoring calls | RD | FADRACICLIB | 1242.37 | 1561 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Investigator (PI) Calls - Medical | RD | FADRACICLIB | 510.15 | 641 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | External Data Reconciliation | RD | FADRACICLIB | 1030.59 | 1294.9 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | External Data Uploads | RD | FADRACICLIB | 935.16 | 1175 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110461 | 50102 | Project management (Ongoing) | RD | FADRACICLIB | 24727.79 | 31069.75 | 372514 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-04-10 00:00:00 | Invoice | 110402 | 50102 | Licensing/System Fees | RD | FADRACICLIB | 2448.42 | 3027.98 | 372385 | CYC065-102 | Test Company 1 |  | 106205 | 2023-03-01 00:00:00
2023-03-31 00:00:00 | Invoice | 110344 | 51620 | RF PM Fee | RD | FADRACICLIB | 266.51 | 329.6 | 916067 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2023-03-31 00:00:00 | Invoice | 110344 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 324.82 | 401.7 | 916067 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2022-03-31 00:00:00 | Invoice | 109247 | 51620 | RF PM Fee | RD | FADRACICLIB | 250.98 | 329.6 | 883323 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2022-03-31 00:00:00 | Invoice | 109247 | 51620 | [NAME] CRT PLT | RD | FADRACICLIB | 101.96 | 133.9 | 883323 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2022-03-31 00:00:00 | Invoice | 109247 | 51620 | RF Ship CRT | RD | FADRACICLIB | 137.26 | 180.25 | 883323 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2022-03-31 00:00:00 | Invoice | 109247 | 51620 | RF Shipper SM Dom | RD | FADRACICLIB | 58.82 | 77.25 | 883323 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2022-03-31 00:00:00 | Invoice | 109247 | 51620 | RF Tempmonitor | RD | FADRACICLIB | 54.9 | 72.1 | 883323 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2022-03-31 00:00:00 | Invoice | 109247 | 51620 | RF Ship Sameday | RD | FADRACICLIB | 82.35 | 108.15 | 883323 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2022-03-31 00:00:00 | Invoice | 109247 | 51620 | RF Fedex Frt | RD | FADRACICLIB | 88.91 | 116.76 | 883323 RI | CYC065-102 | Test Company 2 |  | 106202 | 2023-03-01 00:00:00
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Study Setup Per Site | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 1566
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | SSU Ongoing Activities | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 81.81
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Remote Interim Site Monitoring Visit | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 5378
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Interim Site Monitoring Additional Days on Site | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 4266
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Essential Document / TMF Maintenance | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 5322.17
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Site Central Assessment Notice (SCAN) Reporting | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 1247
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Central Monitoring Clinical Review | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 962.68
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Monitoring Management Ongoing | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 27376.13
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Site Management | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 1352.42
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Medical Management Oversight | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 4104.67
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Patient Eligibility Review | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 649.14
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Project Management (Ongoing) | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 29000
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Functional Oversight | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 8982.85
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | EDC Support | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 303.67
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Lab Reconciliation | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 2930
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Sponsor Teleconferences | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 2309.04
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Internal Team Meetings | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 2648.6
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Patient Profile Programming | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 26972
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | 10% [NAME] | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | -9398.42
2023-04-30 00:00:00 | Accrual | JE130047 | 50105 | Licensing/System Fees | RD | FADRACICLIB |  |  |  | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  | 3027.98
2023-04-01 00:00:00 | Credit Memo | 109089 | 50102 | Project management (Ongoing) | RD | FADRACICLIB | -55935.82 |  | 370980 | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  |  |  | -69176.22
2023-04-01 00:00:00 | Credit Memo | 109089 | 50102 | [NAME] | RD | FADRACICLIB | 5695.39 |  | 370980 | CYC065-102 | Test Company 1 |  | 106205 | 2023-04-01 00:00:00 |  |  |  |  | 7043.53